Test group:CART cells
Sponsors
the First Affiliated Hospital of Zhengzhou University, The First Affiliated Hospital of China Medical University, Anhui Cancer Hospital, Yantai Yuhuangding hospital, Liaoning Provincial Cancer Hospital
Conditions
Advanced digestive system tumorAdvanced gynecological tumorAdvanced lung cancerAdvanced malignant solid tumorAdvanced solid tumorUrinary system tumor
Early Phase 1
Clinical study on the safety and efficacy of CAR-T cells in the treatment of advanced solid tumors
RecruitingChiCTR2100054723
Start: 2022-01-15Updated: 2022-12-05
Clinical study on the safety and efficacy of CART cells in the treatment of advanced urinary system tumors
RecruitingChiCTR2200056139
Start: 2022-01-28Updated: 2024-08-19
A multi cohort study on the safety and efficacy of cart cells in the treatment of advanced solid tumors
RecruitingChiCTR2200056197
Start: 2022-01-28Updated: 2024-08-12
Clinical study on the safety and efficacy of CART cells in the treatment of advanced digestive system tumors
RecruitingChiCTR2200056168
Start: 2022-01-28Updated: 2024-08-12
Clinical study on the safety and effectiveness of CART cells in the treatment of advanced gynecological tumors
RecruitingChiCTR2200057362
Start: 2022-03-11Updated: 2023-10-16
Phase 1
Clinical study on the safety and efficacy of CAR-T cells in the treatment of advanced lung cancer
RecruitingChiCTR2200061555
Start: 2022-07-04Updated: 2023-04-03
Clinical study on the safety and efficacy of CART cells in the treatment of advanced solid tumors
RecruitingChiCTR2200061556
Start: 2022-07-04Updated: 2023-04-03